Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase

Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase

US Patent 10435388 · Granted Oct 8, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD80 variant proteins and uses thereof2025
Peptide compositions and methods of use2025
Cyclic di-nucleotides as stimulator of interferon genes modulators2023
Peptide compositions and methods of use2023
Anti-claudin 18.2 antibodies2022
Substituted pyrimidines as CDK4/6 inhibitors2022
Glucosylceramide synthase inhibitors for the treatment of diseases2021
Histone deacetylase inhibitors2020
Peptide compositions and methods of use2020
Peptide compositions and methods of use2019
Methods for the treatment of erectile dysfunction using fispemifene2019
Histone deacetylase inhibitors2019